D. E. Shaw & Co., Inc. Crinetics Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 39,566 shares of CRNX stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,566

Previous 6,900 473.42%

Holding current value

$2.14 Million

Previous $322,000 450.31%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$42.12 - $51.91 $1.38 Million - $1.7 Million	32,666 Added 473.42%	39,566 $1.77 Million
Q1 2024 May 15, 2024	SELL	$34.76 - $46.81 $351,249 - $473,015	-10,105 Reduced 59.42%	6,900 $322,000
Q4 2023 Feb 14, 2024	SELL	$25.62 - $37.07 $754,252 - $1.09 Million	-29,440 Reduced 63.39%	17,005 $605,000
Q3 2023 Nov 14, 2023	SELL	$15.97 - $30.59 $385,595 - $738,595	-24,145 Reduced 34.2%	46,445 $1.38 Million
Q2 2023 Aug 14, 2023	BUY	$15.73 - $23.6 $1.11 Million - $1.67 Million	70,590 New	70,590 $1.27 Million
Q4 2022 Feb 14, 2023	SELL	$15.49 - $19.05 $88,881 - $109,308	-5,738 Reduced 15.44%	31,417 $574,000
Q3 2022 Nov 14, 2022	BUY	$18.11 - $22.37 $165,923 - $204,953	9,162 Added 32.73%	37,155 $730,000
Q2 2022 Aug 15, 2022	BUY	$16.49 - $27.64 $213,908 - $358,546	12,972 Added 86.36%	27,993 $522,000
Q1 2022 May 16, 2022	SELL	$17.15 - $28.31 $887,701 - $1.47 Million	-51,761 Reduced 77.51%	15,021 $330,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $477,693 - $701,357	24,687 Added 58.65%	66,782 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$16.88 - $25.23 $183,367 - $274,073	10,863 Added 34.78%	42,095 $886,000
Q2 2021 Aug 16, 2021	BUY	$15.9 - $21.15 $496,588 - $660,556	31,232 New	31,232 $589,000
Q3 2020 Nov 16, 2020	SELL	$13.62 - $17.66 $198,593 - $257,500	-14,581 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.04 - $23.23 $190,136 - $338,716	14,581 New	14,581 $255,000

Others Institutions Holding CRNX

# of Institutions

244

Shares Held

78.2M

Call Options Held

268K

Put Options Held

197K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.91B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account